- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06488326
Mulberry Leaf Extract Capsule on Blood Glucose Control in Healthy Volunteers
June 28, 2024 updated by: Pornanong Aramwit, Pharm.D., Ph.D, Chulalongkorn University
Effect of Mulberry Leaf Extract Capsule on Blood Glucose Control in Healthy Volunteers
Volunteers will be divided into 4 groups which are mulberry leaf extract 6 mg capsule, mulberry leaf extract 12 mg capsule, mulberry leaf extract 18 mg capsule, and placebo capsule group.
They will be tested blood glucose levels (taken from the fingertips) before starting.
Then, they will take 1 capsule of the sample one time.
After taking the sample for 30 minutes, they will take 50 g of sucrose in 250 ml of water in 5 minutes.
Then, they will be tested blood glucose levels (taken from the fingertips) at 30, 60, 90, and 120 minutes.
Study Overview
Status
Not yet recruiting
Conditions
Study Type
Interventional
Enrollment (Estimated)
56
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Age 18-60 years
- No diabetes mellitus
- Have blood glucose less than 126 mg/dL
- Wiling to attend the study
Exclusion Criteria:
- Take steroids, psychiatric medicine, thiazide diuretic medicine, and beta blocker medicine within 2 weeks before starting of the study
- Take dietary supplement, herbal substance, and weight-loss medicine within 2 weeks before starting of the study
- Uncontrolled diseases
- History of gastrointestinal tract surgery
- Liver and Kidney diseases
- Pregnancy and lactation
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Screening
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Mulberry leaf extract 6 mg capsule
Take one capsule of the sample one time.
|
Take one capsule of the sample one time.
|
|
Experimental: Mulberry leaf extract 12 mg capsule
Take one capsule of the sample one time.
|
Take one capsule of the sample one time.
|
|
Experimental: Mulberry leaf extract 18 mg capsule
Take one capsule of the sample one time.
|
Take one capsule of the sample one time.
|
|
Placebo Comparator: Placebo capsule
Take one capsule of the sample one time.
|
Take one capsule of the sample one time.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Blood glucose
Time Frame: 120 minutes
|
Volunteers will be measured the blood glucose using blood glucose meter and strip (accuchek) before and after taking the sample for 30, 60, 90, and 120 minutes.
|
120 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
July 1, 2024
Primary Completion (Estimated)
December 30, 2024
Study Completion (Estimated)
February 25, 2025
Study Registration Dates
First Submitted
June 28, 2024
First Submitted That Met QC Criteria
June 28, 2024
First Posted (Actual)
July 5, 2024
Study Record Updates
Last Update Posted (Actual)
July 5, 2024
Last Update Submitted That Met QC Criteria
June 28, 2024
Last Verified
June 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- EC23188-20
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Health, Subjective
-
Istanbul University - CerrahpasaRecruiting
-
Bahçeşehir UniversityNot yet recruiting
-
Alteogen, Inc.CompletedHealth, SubjectiveSouth Korea
-
Indonesia UniversityEnrolling by invitationHealth, SubjectiveIndonesia
-
BMI KoreaCompletedHealth, SubjectiveKorea, Republic of
-
Tel Aviv UniversityCompletedHealth, SubjectiveIsrael
-
Hanmi Pharmaceutical Company LimitedCompletedHealth, SubjectiveKorea, Republic of
-
Sihuan Pharmaceutical Holdings Group Ltd.CompletedHealth, Subjective
-
University of MiamiNational Heart, Lung, and Blood Institute (NHLBI); WestatRecruiting
-
Chulalongkorn UniversityNot yet recruiting
Clinical Trials on Mulberry leaf extract 6 mg capsule
-
Société des Produits Nestlé (SPN)CompletedPost-prandial GlycemiaSwitzerland
-
Phynova Group LtdPeople ScienceRecruitingGlycemic Response | Menopause SymptomsUnited States
-
Azienda Ospedaliera Universitaria Policlinico Paolo...CompletedWeight ManagementItaly
-
Chulalongkorn UniversityRecruitingHealthy Volunteers | Non Diabetic HyperglycemiaThailand
-
Ewha Womans UniversityCHA University; Ministry of Knowledge Economy, KoreaCompleted
-
University of Mississippi Medical CenterCompleted
-
Craig, Nancy, M.D.Completed
-
PepsiCo Global R&DCompletedMood | Cognition | AttentionUnited Kingdom
-
Gadjah Mada UniversityAhmad Dahlan University; Dr. Kariadi General Hospital; PT Konimex; LPDP, Kementerian...RecruitingBreast Cancer Stage IVIndonesia
-
SF Research Institute, Inc.CompletedStress | Weight ManagementUnited States